Al-Dughaishi M, Shalaby A, Al-Ribkhi K, Boudaka A, Boulassel M-R, Saleh J. The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated with Neoadjuvant Chemotherapy. Sultan Qaboos Univ Med J [Internet]. 2019Dec.22 [cited 2024Nov.23];19(4):e277-283. Available from: https://journals.squ.edu.om/index.php/squmj/article/view/3381